Historical record - last NADAC effective date: 2/17/2021
Product Information
NAPROXEN 375 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0736 per EA under NDC 69097085407. Its NADAC has been published 229 times since Oct 12, 2016.
FDA first approved this application on Aug 24, 2011.
The High Outlier badge above means this manufacturer's average price in the naproxen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
375 mg/1
Manufacturer
Cipla USA Inc.NDC
69097085407
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/17/2021
Active Ingredients
NAPROXENApproval Type
Generic (ANDA)
FDA Application
ANDA091305FDA Approved
8/24/2011
On Market Since
7/5/2016
Pharmacological Classes
Price Statistics
The NADAC for NAPROXEN 375 MG TABLET has been published 229 times since Oct 12, 2016, and over the history we have for it it has risen 29.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0736 per EA |
|---|---|
| All-time high | $0.0801 (Nov 13, 2019) |
| All-time low | $0.0548 (Jul 19, 2017) |
| Median price | $0.0653 |
| Average price | $0.0666 |
| Largest weekly change | +14.4% (Apr 17, 2019) |
| Weeks tracked | 229 |
| Tracking since | Oct 12, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+29.3%
Last surveyed Feb 24, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NAPROXEN 375 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN 375 MG TABLET, manufactured by Cipla USA Inc., is $0.0736 per EA (NDC 69097085407), effective Feb 24, 2021.
How has the price of NAPROXEN 375 MG TABLET changed over time?
Over the history we have for it, the NADAC for NAPROXEN 375 MG TABLET has risen 29.3%. It has been tracked across 229 weekly CMS publications since Oct 12, 2016.
What are the highest and lowest recorded NADAC prices for NAPROXEN 375 MG TABLET?
Since Oct 12, 2016, the NADAC for NAPROXEN 375 MG TABLET has ranged from a low of $0.0548 (Jul 19, 2017) to a high of $0.0801 (Nov 13, 2019), with a median of $0.0653 per EA.
Are there cheaper alternatives to NAPROXEN 375 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NAPROXEN 375 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures NAPROXEN 375 MG TABLET?
NAPROXEN 375 MG TABLET (NDC 69097085407) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.